Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
1997 3
1998 1
1999 2
2000 1
2002 19
2003 16
2004 22
2005 17
2006 16
2007 15
2008 28
2009 56
2010 43
2011 32
2012 50
2013 66
2014 44
2015 58
2016 54
2017 62
2018 49
2019 33
2020 59
2021 47
2022 34
2023 50
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

835 results

Results by year

Filters applied: . Clear all
Page 1
Nurse-led approach to standardising the management of iron-deficiency anaemia, achieving the 2-week cancer pathway targets and reducing hospital admissions: practicalities and learnings from a success story.
Reid P, Patterson K, McCulloch E, Walsh L, Murshid A, Kinsella W, Moore A, Skouras T, Smith PJ. Reid P, et al. Among authors: moore a. Frontline Gastroenterol. 2023 Nov 20;15(2):162-169. doi: 10.1136/flgastro-2023-102438. eCollection 2024 Mar. Frontline Gastroenterol. 2023. PMID: 38486670 Free PMC article.
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial.
Bennett C, Woo W, Bloch M, Cheung K, Griffin P, Mohan R, Deshmukh S, Arya M, Cumming O, Neville AM, McCallum Pardey TG, Plested JS, Cloney-Clark S, Zhu M, Kalkeri R, Patel N, Marcheschi A, Swan J, Smith G, Cho I, Glenn GM, Walker R, Mallory RM; Novavax 2019nCoV-311 Study Group. Bennett C, et al. Lancet Infect Dis. 2024 Mar 6:S1473-3099(24)00077-X. doi: 10.1016/S1473-3099(24)00077-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38460525
PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults.
Fenwick N, Weston R, Wheatley K, Hodgson J, Marshall L, Elliott M, Makin G, Ng A, Brennan B, Lowis S, Adamski J, Kilday JP, Cox R, Gattens M, Moore A, Trahair T, Ronghe M, Campbell M, Campbell H, Williams MW, Kirby M, Van Eijkelenburg N, Keely J, Scarpa U, Stavrou V, Fultang L, Booth S, Cheng P, De Santo C, Mussai F. Fenwick N, et al. Among authors: moore a. Front Oncol. 2024 Jan 31;14:1296576. doi: 10.3389/fonc.2024.1296576. eCollection 2024. Front Oncol. 2024. PMID: 38357205 Free PMC article.
835 results